No heparin: Hemostasis achieved using a dual-artery compression device without administration of heparin after trans-radial diagnostic catheterization
Study summary
Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Any patient referred for a diagnostic transradial catheterism
Exclusion Criteria:
* Unable to understand study design or provide informed consent
* Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine
* Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access.
* Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.
Primary outcome measure(s)
Rates of patent hemostasis — within 24 hours after diagnostic angiography Evaluation of patent hemostasis by pulse oximetry
Time to hemostasis — within 24 hours post-procedure
Nursing time involvement — within 24 hours post-procedure Calculation of nursing time required for surveillance and care of hemostasis
Evaluation of complications — within 30 days of procedure Compilation of access site complications such as radial artery occlusion, bleeding, presence and grading of hematomas, etc.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.